Well T7 today is the final day for releasing the 1/4ly and we will know the cash position at 31.12.2013.
For a company that has so much going on a little bit more information as to the progress of the trials would be reassuring.
I believe that the current share price has factored in the cash position and in the absence of news the price will drift south.
The brokers valuation of 12.5c per share has not been achieved because of this.
Now would be the time for some news on the Lupus trial!
Add to My Watchlist
What is My Watchlist?
